Study says: Consumers accept behind-the-counter drugs

December 3, 2007

Study finds consumers approve of behind-the-counter drugs

Two-thirds of Americans believe the FDA should make certain drugs obtainable without a prescription, but only after consultation with a pharmacist, according to a new study by Leo J. Shapiro & Associates. With the FDA currently exploring the public health benefit to consumers of a "behind-the-counter" (BTC) class of drugs, the results of the study show a majority (67%) of consumers are attracted by the convenience and access to their medication BTC, even if insurance doesn't cover the cost. The study of 450 households was conducted in November by telephone. Leo Shapiro is a marketing firm that specializes in the pharmaceutical and healthcare industries. For more information, visit